OcuNex: Began a multi-center Phase II trial

Telios Pharmaceuticals Inc. (TLIO) Product: OcuNex, ophthalmic solution of a peptide containing the cell adhesion sequence arginine-glycine-aspartic acid (RGD) attached to a naturally occuring biopoly...